1. Home
  2. OLB vs MYNZ Comparison

OLB vs MYNZ Comparison

Compare OLB & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The OLB Group Inc.

OLB

The OLB Group Inc.

HOLD

Current Price

$0.90

Market Cap

8.8M

Sector

Technology

ML Signal

HOLD

Logo Mainz Biomed N.V.

MYNZ

Mainz Biomed N.V.

HOLD

Current Price

$1.22

Market Cap

8.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLB
MYNZ
Founded
1993
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8M
8.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
OLB
MYNZ
Price
$0.90
$1.22
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$14.00
AVG Volume (30 Days)
46.1K
188.9K
Earning Date
11-14-2025
12-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,639,651.00
$659,935.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
$5.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$0.92
52 Week High
$2.50
$8.20

Technical Indicators

Market Signals
Indicator
OLB
MYNZ
Relative Strength Index (RSI) 38.43 54.02
Support Level $0.90 $1.00
Resistance Level $1.02 $1.15
Average True Range (ATR) 0.10 0.08
MACD -0.01 0.03
Stochastic Oscillator 3.89 76.27

Price Performance

Historical Comparison
OLB
MYNZ

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Share on Social Networks: